🇨🇦 Systemic and Intra-Thecal Amikacin Therapy in Canada

Systemic and Intra-Thecal Amikacin Therapy (Systemic and Intra-Thecal Amikacin Therapy) regulatory status in Canada.

Marketing authorisation

Systemic and Intra-Thecal Amikacin Therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Systemic and Intra-Thecal Amikacin Therapy approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Systemic and Intra-Thecal Amikacin Therapy in Canada?

Rambam Health Care Campus is the originator. The local marketing authorisation holder may differ — check the official source linked above.